• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

Physical/psychological symptoms similar in atypical and full-threshold anorexia nervosa

byBrandon ChildsandCordelia Ross
March 29, 2016
in Pediatrics, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Adolescents with atypical anorexia nervosa (restrictive eating disorder but patients are normal weight) were more likely to have been overweight/obese, to have lost more weight, and to have lost weight over a more extended period of time when compared to adolescents with full anorexia nervosa.

2. Despite their different weight classes and amount of weight lost, there were no major differences found in the rates of adverse physical or psychological symptoms between the atypical and full anorexia nervosa groups.

Evidence Rating Level: 2 (Good)  

Study Rundown: Atypical anorexia nervosa (AN) is a condition similar to AN except for the fact that the patient is not underweight. In recent years, there has been a dramatic rise in the amount of adolescents admitted to hospitals with eating disorders who are not underweight, but it is unknown if these patients display similar physical and psychological issues as patients with AN. The authors of this study sought to define the physical and psychological profile of these adolescents in comparison to patients with AN. Patients with atypical AN were more likely to have been overweight or obese, to have lost more weight, and to have lost weight over a longer period of time than individuals with full AN. Despite weight status, there were no significant differences in the vital signs, medical instability, or psychiatric conditions between these 2 groups. These results are limited by recall bias for premorbid weight and small sample size. Nonetheless, the findings should encourage pediatric providers to be more aware of patients who lose weight, especially those who originally present as overweight or obese.

Click to read the study, published today in Pediatrics

Relevant Reading: Restrictive eating disorders among adolescent inpatients

RELATED REPORTS

Impact of combined hormonal contraceptives and metformin on metabolic syndrome in women with hyperandrogenic polycystic ovary syndrome and obesity: The COMET-PCOS randomized clinical trial

2 Minute Medicine Rewind December 15, 2025

GLP-1 receptor agonists show little effect on obesity-related cancer risk

In-Depth [retrospective cohort]: Researchers analyzed data from 160 adolescent patients (42 atypical AN, 118 full-threshold AN) at The Royal Children’s Hospital Eating Disorders Program from July 2010 to June 2014. Patients were assessed at the time of initial contact with the clinic, at which point anthropometric measurements, blood pressure, pulse rate, and temperature were measured. Diagnoses were assigned based upon patient responses to the Eating Disorder Examination, psychiatric comorbidities based upon the Mini International Neuropsychiatric Interview, and obsessive compulsive tendencies using validated scales from Yale. Adolescents with atypical AN were more likely than patients with AN to have been overweight/obese (71% vs. 12%, p < .001), to lose more weight (17.6 kg. vs. 11.0 kg., p < .001), and to lose the weight over a longer period of time (13.3 vs. 10.2 months, p = .04). There were no significant differences in pulse rate (11% vs. 15%), bradycardia occurrences (24% vs. 33%), orthostatic instability (43% vs. 38%), or hypothermia (10% vs. 13%) between the 2 groups. The groups also did not differ significantly in rates of psychiatric diagnoses, psychiatric medication use, suicidal ideation, depressive symptoms, or obsessive compulsive features.

Image: CC

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adolescent healthadolescent medicineanorexiaobesityoverweight
Previous Post

Ear infections decreasing in infants

Next Post

Clinical prediction rule assesses harm/benefit of dual antiplatelet therapy after angioplasty

RelatedReports

Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Chronic Disease

Impact of combined hormonal contraceptives and metformin on metabolic syndrome in women with hyperandrogenic polycystic ovary syndrome and obesity: The COMET-PCOS randomized clinical trial

December 19, 2025
Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Weekly Rewinds

2 Minute Medicine Rewind December 15, 2025

December 15, 2025
Many new pediatric asthma cases attributable to obesity
Chronic Disease

GLP-1 receptor agonists show little effect on obesity-related cancer risk

December 8, 2025
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk

November 23, 2025
Next Post
Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors

Clinical prediction rule assesses harm/benefit of dual antiplatelet therapy after angioplasty

Late pregnancy pertussis vaccination may boost passive immunity

2 Minute Medicine Rewind March 28, 2016

No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer

No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial
  • Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry
  • Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.